Company / Operating Margin
Forte Biosciences, Inc. Operating Margin History
FY2018-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-91775.6%
FY2019
5-year range
-91775.6% / -64673.5%
FY2018-FY2019
Trend
-41.9%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-91775.6% in FY2019.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2019, operating margin decreased 41.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | -91775.6% | -41.9% |
| FY2018 | -64673.5% | - |
As of FY2019 · SEC 10-K Annual Filings · Updated Jun 24, 2026